Altimmune, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ALT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

672

Value ($000)

2

Weight

0.0%

2022 Q4 - 2025 Q4 (10 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2	0.0%	672	12/31/2025
2025 Q2	8/14/2025	16	0.0%	4,215	6/30/2025
2025 Q1	5/19/2025	534	0.0%	106,872	3/31/2025
2024 Q4	2/14/2025	666	0.0%	92,392	12/31/2024
2024 Q3	11/14/2024	487	0.0%	79,266	9/30/2024
2024 Q2	8/14/2024	699	0.0%	105,182	6/30/2024
2024 Q1	5/15/2024	185	0.0%	18,200	3/31/2024
2023 Q2	8/11/2023	81	0.0%	19,200	6/30/2023
2023 Q1	5/15/2023	81	0.0%	19,200	3/31/2023
2022 Q4	2/14/2023	900	0.0%	54,700	12/31/2022